Published in

Antibody Reports, 3(3), p. e188, 2020

DOI: 10.24450/journals/abrep.2020.e188

Links

Tools

Export citation

Search in Google Scholar

RB137 and RB138 antibodies recognize human cathelicidin LL37 by ELISA

Journal article published in 2020 by Raffaella Palazzo, Immacolata Pietraforte, Carlo Chizzolini, Roberto Lande, Loredana Frasca ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload

Abstract

LL37 is a cationic antimicrobial peptide (AMP), which can undergo post-translational modifications (PTM), such as citrullination and carbamylation. We demonstrate here that recombinant antibodies RB137 and RB138 are specific for native LL37 and do not recognize modified LL37 (citrullinated and carbamylated). They thus represent tools to assess the presence of native, unmodified LL37 in body fluids by ELISA.